Syracuse University

SURFACE
Syracuse University Honors Program Capstone
Projects

Syracuse University Honors Program Capstone
Projects

Spring 5-1-2015

Differential Activation of Microglia in an in vitro Model of
Intracerebral Hemorrhage
Bhakti Patel
Syracuse University

Follow this and additional works at: https://surface.syr.edu/honors_capstone
Part of the Cellular and Molecular Physiology Commons, Medical Physiology Commons, and the Other
Neuroscience and Neurobiology Commons

Recommended Citation
Patel, Bhakti, "Differential Activation of Microglia in an in vitro Model of Intracerebral Hemorrhage" (2015).
Syracuse University Honors Program Capstone Projects. 826.
https://surface.syr.edu/honors_capstone/826

This Honors Capstone Project is brought to you for free and open access by the Syracuse University Honors Program
Capstone Projects at SURFACE. It has been accepted for inclusion in Syracuse University Honors Program Capstone
Projects by an authorized administrator of SURFACE. For more information, please contact surface@syr.edu.

Differential Activation of Microglia in an in vitro Model of Intracerebral Hemorrhage

A Capstone Project Submitted in Partial Fulfillment of the
Requirements of the Renée Crown University Honors Program at
Syracuse University

Bhakti Yogesh Patel
Candidate for B.S. Degree in Biology
and Renée Crown University Honors
May 2015

Honors Capstone Project in Biology
Capstone Project Advisor: _______________________
Dr. Mary Lou Vallano
Capstone Project Reader:

_______________________
Dr. John Russell

Honors Director:

_______________________
Stephen Kuusisto, Director

Date:

________________________

Abstract
An in vitro model of intracerebral hemorrhage was established to examine the
protective versus cytotoxic roles of microglia in the context of mild versus severe
injury. Co-cultures of microglia, astrocytes, and granule neurons were prepared
from the cerebellar cortex of neonatal rats, and grown in standard medium
containing fetal bovine serum or, in some cases, a serum-free chemically defined
medium. To mimic hemorrhagic stroke, co-cultures grown for 7-8 days in vitro
were challenged with two different concentrations of the toxic blood product
hemin, corresponding to a mild versus a severe brain bleed. Immunocytochemical, real-time RT-PCR, iron deposition, and cell survival assays were
performed to assess the effects of hemin, with emphasis on the functional effector
states of microglia. In cultures grown in serum-containing medium, the lower
concentration of hemin (20 µM) induced significant expression of the protective
enzyme, heme oxygenase 1 (HO-1). Consistent with this, iron deposition was
localized to the microglia in the cultures. Only a modest induction of the
inflammatory molecule TNF-α, and no significant cell death was observed 24 hrs
after hemin addition. In contrast, the higher concentration of hemin (100 µM)
induced greater expression of HO-1, and iron deposition was detected in all three
cell types in the cultures. Moreover, significant and robust induction of the
inflammatory molecules TNF-α, COX-2, iNOS, and significant neuronal death
were observed. These results suggest that microglia are protective and serve to
effectively catabolize hemin when exposed to 20 µM hemin. However,
increasing the hemin concentration to 100 µM appears to exceed the capacity of
the microglia to effectively catabolize the hemin load, resulting in an
inflammatory and cytotoxic environment. Serum proteins, in particular albumin
and hemopexin, can bind blood products such as hemin, and slowly release them
to be processed by microglia after a brain bleed. To test the possible protective
effect of albumin, co-cultures grown in a chemically defined medium lacking
serum were exposed to hemin as described above, with or without co-addition of
an equivalent amount of albumin. In these cultures, significant neuronal death
was observed in response to 20 µM hemin, with essentially total cell death in
response to 100 µM hemin. Addition of albumin to the cultures significantly
decreased the amount of neuronal death in response to both concentrations of
hemin. These data suggest that addition of agents that bind toxic blood products
may serve as protective agents after hemorrhagic stroke. In future studies, this in
vitro model should prove valuable in characterizing the signaling pathways
underlying distinct functional effector states of microglia, and developing
strategies to preserve the protective phenotype.
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Executive Summary
Strokes occur when the brain does not get enough blood, leading to
neuronal death. There are two primary types of strokes, called ischemic and
hemorrhagic. A hemorrhagic stroke occurs after a blood vessel bursts, releasing
blood contents directly into the brain tissue. Although hemorrhagic strokes are
less common than ischemic strokes, they cause greater impairment and more
deaths. The scarcity of treatments available for patients who suffer brain bleeding
shows the importance of research that focuses on factors underlying brain
damage, and what can be done to prevent it. My project uses a cell culture model
to mimic hemorrhagic stroke. We take tissue from the brains of rats and
experimentally grow neurons, astrocytes and microglia to study the roles of
microglia in response to injury that mimics brain bleeding. Microglia can be
protective by internalizing the toxic blood products before they have a chance to
do damage, but microglia can also be overwhelmed by an excessive amount of
blood and become toxic, increasing the amount of damage. Currently, therapies
aimed at inhibiting the functions of microglia are being studied to treat strokes
and other brain injuries. However, we believe that it is important to recognize the
differences between injuries that preserve the protective functions of microglia
versus injuries that result in conversion of microglia to states that make injuries
worse, called cytotoxic. One would not want to use a microglia inhibitor under
injury conditions where microglia are serving a protective role.
To better understand the different states that microglia assume in response
to a brain bleed, we used low and high concentrations of the potentially toxic
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blood product hemin. We reasoned that the low concentration of hemin would be
effectively cleared by the microglia without causing cell damage, whereas the
higher concentration of hemin would lead to microglial overload, and generate
production of toxic molecules causing death of neurons in the cultures. When
hemin is introduced to the environment, microglia and possibly other cells
produce the protective enzyme, called heme oxygenase-1 (HO-1), which breaks
down the hemin into carbon monoxide, biliverdin, and free iron. The amount of
HO-1 mRNA generated was quantified using RT-PCR, which is a technique that
measures RNA expression. Our results showed that more HO-1 was induced as
the concentration and duration of exposure to hemin was increased. Through
staining with hemin-specific antibodies, it was also determined that the HO-1
generation was primarily localized in the microglia. Additionally, we expected
there to be iron deposited in the microglia since iron is a product released when
hemin is broken down. We performed an iron stain and found that, when the cells
are challenged with a low concentration of hemin, the iron is localized within the
microglia. However, when they are challenged with a high concentration of
hemin, the iron is taken up by all the cell types indicating that the microglia alone,
are unable to process the large hemin load. Similarly, there is little or no neuronal
death in response to the low concentration of hemin, but there is substantial
neuronal death in response to the high concentration of hemin, as assessed using
various cell viability assays. Moreover, only the higher concentration of hemin
led to the production of several inflammatory molecules, which are markers of
cell toxicity. These results suggest that microglia are protective and effectively
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break down hemin when exposed to the low concentration. However, increasing
the hemin concentration appears to exceed the capacity of the microglia to
effectively catabolize the hemin load, resulting in an inflammatory and cytotoxic
environment. Using a modification of our culture model, we also observed that
addition of a serum protein, albumin, protected the neurons from dying after
exposure to hemin. These results suggest that added albumin binds the toxic
hemin and serves to protect the neurons. In future studies, our model should
prove valuable in developing strategies to protect the brain against toxic blood
products as occurs after a hemorrhagic stroke.
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Introduction
Ischemic strokes result from the formation of clots in blood vessels, which
prevent delivery of oxygen and nutrients to brain tissue. This type of stroke in the
United States accounts for the majority of all stroke types. Hemorrhagic strokes
result when vasculature weakens and rupture releasing blood directly into the
brain parenchyma in cases of intracerebral hemorrhage. Although hemorrhagic
strokes make up only 10-15% of all stroke types, they are much more devastating
in terms of mortality and morbidity compared to ischemic stroke. For example,
about 35-52% of people who have hemorrhagic strokes die within 30 days (Taylor
and Sensing, 2013). Currently, there is a lack of effective treatments for patients
who suffer intracerebral hemorrhages, demonstrating the importance of research
aimed at understanding the pathogenesis of neuronal damage following
hemorrhagic stroke, and possible strategies to prevent or reduce the extent of the
injury.
We are using co-cultures of neurons, astrocytes and microglia as a simple
and convenient model to assess the functional effector states of microglia in
response to different types of injury. The earliest studies on microglia defined two
functional states; resting, which coincided with a ramified morphology, and
active, which correlated to an amoeboid morphology and expression of a host of
gene products that served to mobilize the microglia to the site of injury and
promote phagocytosis (Ravish et al. 1999; Streit et al. 2002; Hanisch and
Kettenmann 2007; Ransohoff and Perry 2009; Salter and Beggs 2014). Studies
done more recently, have shown that microglia assume a range of phenotypes
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depending on the duration and extent of injury. Resting microglia exhibit a highly
ramified phenotype with numerous processes and a small compact soma. These
cells are not stagnant but, instead, are constantly surveying the local environment
for minor damage. When exposed to mild or moderate injuries, they transition to a
less ramified, phagocytic phenotype in which they are protective and function to
remove substances from the environment to limit inflammation and restore
homeostasis. However, with more severe injuries, microglia may lose their
phagocytic functions and transition to rounded, pro-inflammatory phenotypes that
actually enhance tissue damage (Hanisch and Kettenmann 2007; Salter and Beggs
2014). From a clinical prospective, microglia inhibitors are being actively
investigated in humans for a variety of brain injuries such as ischemic and
hemorrhagic stroke, multiple sclerosis, neurodegenerative diseases, and numerous
formed of brain trauma and cerebral edema (Bachstetter et al. 2012; Bachstetter et
al. 2013; Sloka et al. 2013; Neher et al. 2013; Xie et al. 2014; Chen et al. 2014;
Huang et al. 2014; Kabati et al. 2014). However, we believe it is important to
distinguish between the different phenotypes of microglia because treatment to
inhibit microglia functions may be useful only when they have converted to the
cytotoxic, inflammatory phenotype. If inhibited while assuming the other states,
the protective functions of the microglia may be lost, thereby preventing the cells
from containing the damage and returning the environment to homeostasis.
In our laboratory, we use different concentrations of the toxic blood
product hemin (20 µM and 100 µM) to model a mild to moderate versus a severe
hemorrhagic stroke. When a blood vessel ruptures in the brain, the blood cells that
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surround brain tissue lyse releasing hemoglobin and other toxic blood products.
Hemoglobin then breaks down into heme (or hemin), a product that may be toxic.
Microglia take up these blood products and catabolize them. To protect against
oxidative injury, there is an induction in the enzyme heme oxygenase-1 (HO-1)
within microglia and perhaps other cell types, which catabolize heme into carbon
monoxide, biliverdin, and free iron (Robinson et al., 2009; Dang et al., 2011). Our
working hypothesis is that microglia transition to distinct functional effector states
in response to different hemin loads, corresponding to mild to moderate versus
severe injury. When the hemin load is mild or moderate, we predict that microglia
are able to effectively internalize the hemin, catabolize it without demonstrating a
robust inflammatory response, and return the system to homeostasis, avoiding
neuronal damage or death. When the hemin load becomes excessive, we predict
the microglia are overwhelmed and are unable to effectively manage the removal
and catabolism of hemin from the environment. In such cases, neuronal death and
expression of inflammatory markers are expected. To test these hypotheses, after
our cultures are exposed to low and high concentrations of hemin, alterations in
microglia effector states were examined using immunohistochemistry techniques,
real-time RT-PCR assays, an iron deposition assay, a phagocytosis assay, and
live-dead assays to assess neuronal survival.
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Methods
Tissue Culture:
Granule cell-enriched cultures were prepared as described by Vallano et
al. (1996). However, for this study, the mitotic inhibitor AraC was omitted from
the growth medium to promote the growth of astrocytes and microglia (BeamanHall et al. 1998). Briefly, the cerebella of 8-day-old Sprague-Dawley rats were
minced, trypsinized, and triturated to separate cells. The cells were plated at a
density of 1.25 x 106 cells/ml of medium onto 12-well Corning dishes (for livedead assays, and RT-PCR assays) or 24-well Corning dishes containing glass
coverslips precoated with poly-L-lysine (for immunocytochemistry). They were
then incubated at 37°C in a humidified atmosphere containing 5% CO2/95% air
(pH 7.4). Cultures with abundant microglia and astrocytes were grown in basal
Eagle’s medium with Earle’s salts, enhanced with heat-inactivated fetal bovine
serum (10%), gentamicin sulfate (100 µg/ml), and L-glutamine (2mM). To ensure
the lasting survival of cerebellar granule neurons (CGNs), 20mM KCl (25mM
f.c.) was added to the growth medium (Thangnipon et al. 1983; Kingsbury et al.
1985; Gallo et al. 1987). At 7-8 days in vitro (DIV), the CGNs mature and
develop sensitivity to addition of excitotoxic agents (Leahy et al. 1994), and
hemin experiments were done at this phase of growth. Although the medium was
not replaced during this time, the addition of 5.5 mM glucose at 6 DIV ensured
the lasting survival of the cells (Schramm et al. 1990). Phase contrast microscopy
was utilized in evaluating the viability of the cells regularly.
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Excitotoxicity:
Cell viability was assessed using a lactate dehydrogenase (LDH) assay as
described by Decker and Lohmann-Matthes (1988). Fluorescent staining
techniques were also used to visualize live and dead cells using a live/dead kit in
which calcein was used to stain living cells and PI to stain dead cells (Invitrogen).
Hemin (20 µM or 100 µM) was added and, at 24 hours, the relative amounts of
living and dead cells were quantified. Up to four fields per coverslip comprising
of at least one hundred cells were photographed. The total number of living and
dead CGNs, in relation to microglia and astrocytes were also quantified to
estimate the relative proportions of glia and neurons in the cultures. In one series
of experiments, kainic acid was used to model ischemic injury and, for
comparative purposes, I will present some of these data that were done by another
laboratory member.
Immunocytochemistry:
Phase-contrast microscopy and immunocytochemical staining with the
microglial markers ED1 and Iba1 (estimated as ~11% of cells at 7-8 DIV), and
the abundant neuronal protein β-tubulin (not shown) were used to observe the
production of abundant microglia and neurons in culture. Astrocytes were labeled
using an antibody against GFAP (estimated as ~10% of cells at 7-8 DIV).
Cultures were fixed with 4% paraformaldehyde 24 hrs after toxicity (7-8 DIV),
permeabilized with 0.3% Triton X-100 and 4% normal donkey serum in
phosphate-buffered saline (PBS) was added for 20 min at room temperature.
Following the manufacturer’s protocol, the following antibodies were added to

5

the cultures: ED1(1:300) mouse anti-rat monoclonal antibody, Iba1(1:1000) antirabbit polyclonal, GFAP (1:1000) anti-rabbit polyclonal antibody, iNOS (1:1000)
anti-rabbit polyclonal were added for 24 hrs at 4°C. Cultures were then washed 3x
with PBS and incubated in Alexa fluor 488 donkey anti-mouse secondary
antibody (1:400) or Alexa fluor 488 donkey anti-rabbit (1-400), and Alexa fluor
594 donkey anti-rabbit (1:400) for 1 hr at room temperature. Before they were
photographed under a fluorescent microscope, Vectashield Antifade (Vector
Laboratories) or Vectashield Antifade with PI if ED1 was used to mount
coverslips. Cells positively labeled with Iba1 in two randomly photographed
fields per coverslip were counted in 3 different cell culture preparations.
Phagocytosis assay:
A phagocytosis assay was performed using 5.5 µm polystyrene beads as
previously described (Bocchini et al. 1988a, 1988b). Briefly, cultures were
prepared as above and plated on 12mm glass coverslips at a density of 1.25 x 106
cells/ml and cultured for 7-8 DIV. Then, 1.5 µl/ml of 5.5 µm fluorescent
microspheres were added directly to the cultures and incubated for 1 hr at 370C.
To remove lingering microspheres, cells were washed three times with PBS
before being fixed with 4% formalin in PBS. Iba1 or GFAP antibodies were used
as detailed above to label cells. Four random fields were photographed.
Iron stain:
To visualize hemin uptake into cells, iron deposition was examined. After
hemin exposure for 24 hrs, cultures were washed three times with PBS and then
incubated with 5% potassium ferrocyanide for 30 minutes. After the removal of
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the 5% potassium ferrocyanide, the cultures were exposed to HCl for 30 minutes.
DAB-NI without H2O2 from the Vector Kit was added for 15 minutes followed by
DAB-NI with H2O2 for 15 minutes. The cultures were washed with PBS three
times before four random fields were photographed.
RT-PCR:
Real-time quantitative RT-PCR (qRT-PCR) analysis was done to examine
the induction of mRNAs reflecting the expression of heat shock protein (HO-1
and inflammatory molecules (TNF-α, COX-2, iNOS) using a Light-cycler 480
System (Roche Applied Sci) using SYBR Green, a fluorescent double-stranded
DNA Dye as previously described by our laboratory (Gerber et al. 2010). Samples
were analyzed in triplicate PCR reactions on a single 384 well plate and the data
was quantified. Amplification in the absence of template was evaluated to ensure
lack of signal due to primer dimerization and extension. To verify the presence of
a single amplicon in each reaction well, end point melt-curve analysis was done.
The ∆∆CT method (with 18S as an internal reference) was done to analyze the
data, and a repeated measures ANOVA model using the ∆CT data. Validity of the
∆∆CT method was confirmed by indicating equivalent efficiencies of
amplification of the 18S RNA normalization control versus the target mRNAs
over a range of serial dilutions. The primer sets used are shown in Table 1.
Statistical analysis:
Values are presented as mean ± standard deviation of the mean. Analysis
of Variance (ANOVA) and Fisher’s Protected Least Significant Difference
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(PLSD) or Tukey/Kramer post hoc test were used to compare the groups
statistically. A probability of p < 0.05 is considered statistically significant.
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Results
Co-cultures of microglia, astrocytes and neurons:
Figure 1 is a representative image showing the presence of three primary
cell types in our co-cultures, which were fixed at 8 DIV. Numerous rounded
microglia are shown in green using the microglial marker Iba1. Many fibrous
astrocytes are shown in red using the astrocyte marker GFAP. The nuclear stain
Hoeschst was used to stain the nuclei of all cells in the culture. The image shows
several clusters of blue nuclei throughout the culture that are not labeled with
microglia or astrocytes markers, and corresponding to granule neurons.
Phagocytic activity of microglia:
Past studies have demonstrated that both microglia and astrocytes have
phagocytotic activity, but most studies show that microglia are the primary
phagocytotic cells in the brain. (Bechmann and Nitsch 1997; Ito et al. 2007;
Koizumi et al. 2007; Neher et al. 2013). To determine whether the microglia are
the primary phagocytic cells in our co-cultures, 5.5µm fluorescently labeled
polystyrene beads were utilized. The cells were grown for 7-8 DIV and the beads
were added for 1 hour. The cultures were then washed, fixed and stained with an
antibody against Iba1 to label the microglia or an antibody against GFAP to label
the astrocytes. As shown in the representative example in Figure 2, many beads
(red) were observed within the Iba1 labeled microglia (green), but not the GFAP
labeled astrocytes (green). Similar results were observed in four different culture
preparations. These data demonstrate that the microglia in our cultures are indeed,
the primary phagocytic cells.
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Iron deposition within microglia & other cell types:
When heme is degraded by HO-1 into carbon monoxide and biliverdin,
iron is released as a byproduct (Robinson et al., 2009; Dang et al., 2011). To
observe the cell types in which the iron deposition occurs in response to different
concentrations of hemin, 20 µM hemin or 100 µM hemin were added for 24 hrs,
and then the cultures were stained for the presence of iron. Two representative
preparations are shown in Figure 3, and similar results were observed in five
different culture preparations. As shown, when the cultures are exposed to the 20
µM hemin, which we propose corresponds to a mild-moderate injury, iron was
localized primarily to the microglia. However, the addition of 100 µM hemin
corresponding to a more severe injury, appears to overwhelm the microglia
resulting in iron deposition in all the cell types throughout the cultures. These data
demonstrate that microglia take up hemin from the environment, but there is a
limit above which they cannot handle the hemin load. Thus, the hemin is able to
gain entry into microglia as well as astrocytes and neurons in the culture.
HO-1 induction within microglia:
HO-1 is a protective enzyme that is induced in response to various injury
models including models of hemorrhagic stroke (Robinson et al., 2009; Dang et
al., 2011). When hemin enters the microglia, one would expect HO-1 mRNA and
protein to be generated. To test this, real-time RT-PCR assays were performd at
three different time points after addition of 20 µM hemin or 100 µM hemin to the
cultures. As shown, there is a significant induction of HO-1 in response to both
concentrations of hemin, and these show the expected concentration and time
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dependence (Figure 4A). Specifically, the fold induction of HO-1 in response to
20 µM hemin was significant at the 3 hr (~9-fold increase) and 12 hr (~17-fold
increase) time points. An even greater induction of HO-1 was observed in
response to addition of 100 µM hemin, and was significant at all time points
examined. To verify that HO-1 protein as well as mRNA is induced in a
concentration-dependent manner, western immunoblotting was performed 12 hrs
after addition of 20 µM hemin or 100 µM hemin. Figure 4E shows that there is
little detectable HO-1 in control cultures, and that a concentration-dependent
increase in HO-1 protein is observed after hemin challenge (actin was used as a
loading control). To determine if microglia are the primary source of HO-1
protein induction, double-staining immunocytochemistry with antibodies against
the microglia marker ED1 and antibodies against HO-1 was performed 12 hrs
after addition of hemin (Figure 4C). Immunocytochemistry images show the
induction of HO-1 (green) is primarily localized in the microglia (red).
Neurotoxicity in response to hemin:
To measure the neurotoxicity in response to 20 µM hemin and 100 µM
hemin, a LDH assay was done 24 hrs after the addition of the hemin. Insignificant
death was observed in response to the 20 µM hemin challenge, compared to
control cultures, but significant cell death was observed in response to the 100
µM hemin (Figure 5A). Using a caspase-3 death marker, it was determined that
the cell death occurs in the granule neurons (green) and not in the microglia
(Figure 5B-D). Note that the caspase 3 experiments were performed by another
member of the laboratory.
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Expression of inflammatory molecules:
When exposed to injury, such as an intracerebral hemorrhage, microglia
can convert to a cytotoxic phenotype, which is associated with the expression of
inflammatory molecules. To determine if there is a difference in the expression of
inflammatory molecules in response to different concentrations of hemin, we
assayed TNF-α, COX-2 and iNOS mRNA expression using real-time RT-PCR.
TNF-α is an early cytokine in the injury cascade, and we observed a strong and
significant induction of TNF-α in response to 100 µM at both the 1 and 3 hr time
points, approaching 30-fold induction. In contrast, a modest 7-fold induction of
TNF-α was observed in response to the 20 µM hemin only at the 3 hr time point
(Figure 6). Significant induction of COX-2 mRNA (approaching 65-fold), which
is downstream of TNF-α in the injury cascade, is only observed in response to
100 µM hemin and only at the 12 hr time point (Figure 7). Similarly, significant
induction of iNOS mRNA (approaching 450-fold) is only observed in response to
100 µM hemin, again only at the 12 hr time point (Figure 8). Also shown is
localization of iNOS to microglia in response to 100 µM hemin (Figure 8).
Altogether, the cell death and RT-PCR data indicate that the low concentration of
hemin does not trigger significant neuronal death and only induces a mild
inflammatory response. Alternatively, the high concentration of hemin leads to
significant neuronal death, and a robust inflammatory response.
Phagocytosis of dead neurons by microglia:
To measure the ability of microglia to phagocytose dead CGNs, a livedead assay was performed in which cells were exposed to 20 µM hemin and 100
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µM hemin. As shown in Figures 9A-B, there were limited dead CGNs (red) in the
control culture as well as the culture challenged with 20 µM hemin after 24 hrs.
However, there was significant death in response to the 100 µM hemin (Figure
9C). Despite the presence of microglia, the dead CGNs were not phagocytosed.
For comparative purposes, results of a live-dead assay performed in our lab using
250 µM kainate to mimic an ischemic injury are presented. In this injury model,
there were very few dead CGNs after 24 hrs indicating that phagocytosis had been
completed by this time (Figure 9E). We can be sure there was CGN death after 24
hrs by looking at the histogram presented in Figure 9F in which the addition of
AraC (to decrease glial growth) and kainate is shown to increase cell death. To
observe the phagocytic activity, cultures were fixed 3 hrs after kainate exposure,
and numerous dead neurons (red) were visible within the ED1 labeled phagocytic
microglia (Figure 9G). This discrepancy in the activity of the microglia in
response to hemin verses the kainate indicates that the microglia are able to engulf
dead neurons but the addition of high concentrations of hemin compromises their
phagocytic function.
Defined medium and protection by albumin
The presence of serum proteins, such as albumin and hemopexin, can bind blood
products such as hemin, and slowly release them to be processed by microglia
after a brain bleed (Belayev et al., 2005). We examined the protective effect of
serum albumin against hemin-induced neuronal death in our co-cultures. To test
this, we used co-cultures grown in a chemically defined medium that does not
include fetal bovine serum in conjunction with hemin addition plus or minus co-
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addition of albumin, followed 24 hrs later by a live-dead assay. As exemplified in
Figure 10 (and observed in 3 separate culture preparations), significant cell death
was observed in response to both 20 µM hemin and 100 µM hemin 24 hours after
its addition, with essentially total neuronal death in response to the higher
concentration. The significant neuronal death observed after addition of 20 µM
hemin is not unexpected since the growth medium does not contain serum
proteins, unlike the data shown in Figure 9 (top panels). Co-addition of an equal
concentration of albumin (20 µM and 100 µM) to the cultures proved to be
protective, and significantly decreased the amount of cell death in response to
both concentrations of hemin (Figure 10).
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Discussion
Although hemorrhagic strokes are less common than ischemic strokes,
they have a significantly higher morbidity and mortality (Taylor and Sensing,
2013). Currently, we lack effective treatments for individuals who have
intracerebral hemorrhages. Thus, there is a critical need to understand more about
the genesis of the injury process, and also to develop strategies to ameliorate the
extent of tissue damage. Scientific evidence shows that microglia impact, and are
impacted by, astrocytes and neurons (Sudo et al. 1998; Rosenstiel et al. 2001;
Kettenmann et al. 2011; Ousman and Kubes 2012). Microglia in different brain
regions also demonstrate functional and morphological heterogeneity (Lawson et
al. 1990; Elkabes et al. 1996; Ren et al. 1999; de Haas et al. 2008). To accurately
explore microglia functional effector states in vitro, we co-culture microglia,
astrocytes and neurons using cerebellar cortex as our tissue source. Thus, all cells
in the co-cultures come from the same brain region. To promote the growth of the
glial cells in our co-cultures, we omit the mitotic inhibitor, AraC, which is
typically included in the growth medium to enrich CGNs (Thangnipon et al. 1983;
Kingsbury et al. 1985). As exemplified in Figure 1, we estimate that at 7-8 DIV
microglia and astrocytes represent ~11% and ~10%, respectively, of the cell
population, which is similar to what would be found in vivo. In summary, we
observe that microglia and astrocytes proliferate when AraC is not added to the
medium so that neuron-glia co-cultures from the same brain region can be
examined in our injury model.
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When placed in primary culture, microglia assume an amoeboid shape and
they express ED1 indicating that are not true “resting” microglia, which
predominate in brain tissue and exhibit a highly ramified morphology, compact
cell soma, and no expression of ED1 (Damoiseaux et al. 1994; Ito et al. 2001).
The basal state of these microglia in our co-cultures is not characterized by
expression of inflammatory molecules (Figures 6-8), and they are effective
phagocytes when challenged with a cargo such as latex beads (Figure 2).
Similarly, when challenged with the lower concentration of hemin, the microglia
effectively contain the hemin load, as shown by iron deposition localized to
microglia only (Figure 3), only a modest induction of one of the inflammatory
markers at a single time point (TNF-α at 3 hours, Figure 6), and no significant
neuronal death (Figure 5). Importantly, there was significant induction of HO-1
protein and mRNA in response to 20 µM hemin, demonstrating that the amount of
hemin used to challenge the cultures was sufficient to induce a microglia
response. When challenged with the higher concentration of hemin, the microglia
appear to convert to an inflammatory (Figure 6-8), possibly cytotoxic phenotype
that is unable to phagocytose dead neurons (Figure 5, Figure 9/upper panels).
Consistent with this, iron deposition is observed throughout the culture (Figure 3).
Not unexpectedly, there was even greater induction of HO-1 protein and mRNA
in response to 100 µM hemin (Figure 4). Challenge of co-cultures with a
different toxic agent, kainate, was used to demonstrate that microglia in the cocultures are able to effectively phagocytose essentially all of the dead neurons
within a 24 hour time period (Figure 9, lower panels). Possibly, the phagocytic
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function of microglia is compromised when they are actively catabolizing hemin.
For example, Mairuae and associates (2011) reported that iron accumulation
interfered with the ability of microglia to phagocytose zymosan.
For effective treatment of humans with hemorrhagic stroke, it is crucial to
distinguish between microglial functional effector states. In cases of mild-tomoderate injury, for example our 20 µM hemin condition, microglia appear able
to effectively remove and catabolize the hemin without mounting a robust
inflammatory response, and there is no observable cell death. Thus, it would be
counter-productive to inhibit these important protective functions of microglia if
such a situation was observed in the patient. In contrast, cases of severe or
sustained injury, for example our 100 µM hemin condition, microglia appear
unable to effectively remove and catabolize the hemin. Consistent with this, iron
is deposited in all cell types in the culture (Figure 3). Moreover, they mount a
robust inflammatory response, and there is profound cell death. These data are in
good agreement with studies using other model systems, where significant
induction of TNF-α, COX-2 and iNOS in microglia exacerbate neuronal death
(Bal-Price and Brown, 2001; von Bernhardi et al. 2007; Cho et al. 2008; Blaylock
2013; Xing et al. 2015). Thus, it maybe useful to inhibit this potentially cytotoxic
state that microglia have assumed, but only if one can preserve the protective
functions while so doing. It might prove difficult to establish the appropriate
conditions to achieve this goal. Another possible strategy would be to promote
microglial proliferation, so as to avoid their being overwhelmed by the hemin
load. Finally, our studies using cultures grown in chemically defined medium
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indicate that administration of agents that bind toxic blood products, and slowly
release them for catabolism by microglia, may attenuate neuronal damage. Future
studies using our model will explore the potential value of such strategies.
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Appendix 1

Table 1: Primers used for PCR
Name

Sense

Antisense

TNFα

5’-GTAGCCCACGTCGTAGCAAA-3’

5’-CCCTTCTCCAGCTGGGAGAC-3’

COX2

5’-CCATGTCAAAACCCGTGGTGAATG-3’

5’-ATGGGAGTTGGGCAGTCATCAG-3’

iNOS

5’-GCAGAATGTGACCATCATGG-3’

5’-ACAACCTTGGTGTTGAAGGC-3’

18S

5’-CGCCGCTAGAGGTGAAATTC-3’

5’-TTGGCAAATGCTTTCGCTC-3’
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Appendix 2

Figure 1: The three primary cell types in our co-cultures. Microglia labeled green
with an Iba1 marker, astrocytes labeled red with a GFAP marker, and clusters of
neuronal nuclei labeled blue with Hoechst.
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Appendix 3

Iba1
A

GFAP
B

5.5μm

Figure 2: Phagocytic activity of microglia demonstrated by the presence of 5.5
µm beads within the (A) Iba1 labeled microglia and the absence of beads within
the (B) GFAP labeled astrocytes.
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Appendix 4

Prep A

Prep B

20 μM

100 μM

Figure 3: Deposition of iron within microglia and other cell types observed in
cell Prep A and cell Prep B after the addition of 20 µM hemin and 100 µM hemin.
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Appendix 5
A

B

n=5

Control

C

Hemin 20

D

Hemin 100

E

Figure 4: (A) Induction of HO-1 mRNA in response to 20 µM hemin and 100
µM hemin, as assessed by real time RT-PCR assays. (B-D) Immunocytochemistry
images taken 12 hours after exposure to 20 µM hemin and 100 µM hemin
showing the localization of green-labeled HO-1 protein within the red-labeled
ED1 protein that is a microglia marker. E. Western immunoblot of hemin protein
expression 12 hrs after addition of control, 20 µM hemin, or 100 µM hemin.
Actin loading controls are shown in the lower panels.
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Appendix 6

A

B

Control

C

Hemin 20

D

Hemin 100

Figure 5: (A) Neurotoxicity measured in response to 20 µM hemin and 100 µM
hemin using a LDH assay, performed 24 hours following hemin addition. (B-D)
Cell death observed in granule neurons labeled green using a caspase-3 death
marker (green label).
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Appendix 7

Figure 6: TNFα mRNA induction in response to 20 µM hemin and 100 µM
hemin, as assessed by real-time RT-PCR assays.
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Appendix 8

Figure 7: COX-2 mRNA induction in response to 20 µM hemin and 100 µM
hemin, as assessed by real-time RT-PCR assays.
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Appendix 9

A

B

Figure 8: A. iNOS mRNA induction in response to 20 µM hemin and 100 µM
hemin, as assessed by real-time RT-PCR assay. B. Immunocytochemical staining
with ED1 antibodies to label microglia (red) co-localize with iNOS expression
(green) after addition of 100 µM hemin.
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Appendix 10

A

Control

B

20µM Hemin

C

100µM Hemin

A

D

Control

G

3 hour

E

Kainate 250µM

F

Figure 9: (A-C) Challenge with 20 µM hemin results in little death while
exposure to 100 µM hemin results in extensive CGN death. Despite the presence
of microglia, the dead CGNs (red) were not engulfed after 24 hrs. (D-E) When
challenged with 250 µM kainate, to mimic an ischemic injury, there is an absence
of dead (red) CGNs after 24 hrs indicating that phagocytosis is complete by this
time. (F) The histogram in panel F shows that there was significant CGN death
after 24 hrs (Re: -AraC conditions showing ~66% cell death after kainite
exposure). (G) To observe the phagocytic activity directly, the cultures were fixed
3 hrs after exposure to kainate. This image reveals the presence of numerous dead
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neurons (red) within Iba1 labeled phagocytic microglia (green). Note that the
magnification in this image is ~ 2x greater than those in images A-E.
Appendix 11

A

Define Control

B

Define Hemin 20

C

D Define Hemin 20 + albumin

Define Hemin 100

E Define Hemin 100 + albumin

Figure 10: Co-cultures were grown in a chemically defined medium that does not
include fetal bovine serum. Vehicle control (A) or hemin was added in the
absence (B, C) or presence (D, E) of an equal amount of albumin (20 µM or 100
µM), and live-dead assays were done 24 hours later. Living cells are shown in
green; dead cells are shown in red.
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